|Bid||30.77 x 1100|
|Ask||30.88 x 1000|
|Day's Range||30.60 - 31.73|
|52 Week Range||10.78 - 31.73|
|Beta (5Y Monthly)||2.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 28, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.50|
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
MEDNAX's (MD) Q1 results reflect lower costs. However, the same is partly offset by softer revenues.
With me today are Mark Ordan, our CEO; and Mark Richards, our CFO. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995.